Christopher Woelk is Head of Systems Biology at Merck’s Exploratory Science Center in Cambridge, MA, where he has been since 2017. Prior to working at Merck (2013 to 2017) he was an academic Professor in Genomics and Bioinformatics at the University of Southampton in the United Kingdom. During 2002 to 2013 he worked as an Associate Professor at the University of California San Diego and directed the Genomics Core at the Center for AIDS Research. Christopher’s research aims to bring the powerful techniques associated with bioinformatics and machine learning classification to reverse translational studies of clinical trials in order to identify new targets for intervention and biomarkers for patient stratification. He has publications spanning a number of disease areas (infectious diseases, microbiology, mental health, oncology and vaccinology) that utilized innovative techniques related to omics technologies, bioinformatics and systems biology. His current research goal is to identify an immunomodulatory target in the microbiome space in order to improve outcomes to immunotherapy or infectious disease vaccines.